Alcyomics
Anne Dickinson is an Emerita Professor at Newcastle University's Translational and Clinical Research Institute and Professor of Marrow Transplant Biology, with 30 years of experience in haematopoietic stem cell transplantation and post-transplant complications, particularly graft versus host disease. Anne has developed an in vitro predictive model to improve therapy and understand immunobiology and genomics, successfully securing EU funding for multiple research projects since 1998. In addition, Anne founded Alcyomics Ltd in 2007, a company focused on testing novel pre-clinical monoclonal antibodies to combat graft versus host disease, inspired by the Northwick Park disaster in 2006. Academic credentials include a Ph.D. in Pharmacy from the University of Nottingham and a Bachelor's Degree in Biochemistry with Microbiology from the University of Leeds.
This person is not in any teams
Alcyomics
Alcyomics is a specialist clinical research organization (CRO) supporting the pharmaceutical, biotechnology, and cosmetics industries. We offer full assay services and technical consultancy in immuno-toxicology. This is underpinned by our patented human in vitro skin assay platform, Skimune®, which provides highly sensitive detection of adverse immune reactions for pre-clinical testing of small and large molecule drugs, monoclonal antibodies, cellular therapies, cosmetic compounds etc. plus many more. Further to our immunotoxicity platforms we also specialise in 3D assay design, optimisation and validation. We have a number of 3D assays in-house such as; - Autologous skin model, Skimune 3D, for high-throughput immunotoxicity testing. - 3D innervated skin model is based in a 96-well scaffold system and has been specifically validated to detect peripheral toxicity against monoclonal antibodies and chemical insults. - Bioprinted osteo-chondral model incorporates the complex environment present in osteoarthritis. - Autologous atopic dermatitis models incorporating immune cellular function to assess compound function, efficacy and toxicity. From our state of the art facilities based within the custom built Biosphere labs in Newcastle-upon-Tyne, UK, we provide assured, experienced, professional assay support and consultancy to local, national, and international clients. Our Mission at Alcyomics is to provide robust in vitro human assays to the pharmaceutical, biotechnology, chemical and cosmetic industries that enable early detection of adverse immune reactions, reducing risk and cost in the development of drugs and compounds. www.alcyomics.com